We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Gene-Sequence Scanner Analyzes More Data

By Biotechdaily staff writers
Posted on 11 Jul 2005
The new GeneChip scanner (GCS) 3000 7G allows the analysis of microarrays that feature 500% more data than previous generations.

With the ability to scan smaller features, ranging in size from 2.5 µm to 0.51 µm, the new scanner supports the latest high-density GeneChip microarrays for tiling, all-exon, and single nucleotide polymorphism (SNP) genotyping research. More...
The new scanner is the product of Affymetrix, Inc. (Santa Clara, CA, USA). It is designed to provide peak scanning performance for all operations, including RNA expression and DNA analysis. The scanner is compatible with data from previous experiments using GeneChip microarrays as well as other instruments and software of Affymetrix.

Specific features of the GCS 3000 7G include a new dual processor workstation and software updates for processing and analyzing up to five times as much data per experiment, and an improved autofocus algorithm for scanning standard-size 49-format microarrays 30% faster than the original GSC. In addition, a patented scanning system called the Flying Objective provides image uniformity and accuracy. High-numerical-
aperture optical architecture provides consistent excitation and emission paths over the entire scan field.

"We designed the original GCS 3000 to be forward-compatible, requiring only a simple upgrade to support the next-generation of high-density microarrays that develop as GeneChip technology continues to advance,” observed Chip Leveille, vice president of Product Technologies Group, Affymetrix.




Related Links:
Affymetrix

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.